• Badri M, Cleary S, Maartens G et al. (2006) When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study Antiviral Therapy 11, 6372.
  • Bisson GP, Gaolathe T, Gross R et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3, e1725.
  • Brinkhof MW, Pujades-Rodriguez M & Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 4, e5790.
  • Coetzee D, Hildebrand K, Boulle A et al. (2004) Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18, 887895.
  • Dorrington R, Bourne D, Bradshaw D, Laubsher R & Timaeus I (2001) . The Impact of HIV/AIDS on Adult Mortality in South Africa. Medical Research Council, Cape Town.
  • Egger M, May M, Chene G et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360, 119129.
  • Egger M, Spycher B, Sidle J et al. (2009) Correcting mortality for loss to follow up: a graphical approach applied to ART programmes in resource-limited settings. 5th IAS Conference on HIV Pathogenesis and Treatment Abstract no. WEPED173. 2009.
  • Fairall LR, Bachmann MO, Louwagie GM et al. (2008) Effectiveness of antiretroviral treatment in a South African program: a cohort study. Archives of Internal Medicine 168, 8693.
  • Geng EH, Emenyonu N, Bwana MB et al. (2008a) Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300, 506507.
  • Ivers LC, Kendrick D & Doucette K (2005) Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clinical Infectious Diseases 41, 217224.
  • Keiser O, Orrell C, Egger M et al. (2008) Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS Medicine 5, e148.
  • Laurent C, Ngom Gueye NF, Ndour CT et al. (2005) Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. Journal of Acquired Immune Deficiency Syndromes 38, 1417.
  • Lawn SD, Myer L & Wood R (2005) Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world? Clinical Infectious Diseases 41, 16831684.
  • Mocroft AJ, Lundgren JD, D’Armino MA et al. (1997) Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. International Journal of Epidemiology 26, 400407.
  • Morgan D, Mahe C, Mayanja B et al. (2002) HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 16, 597603.
  • National Department of Health (2004) National Antiretroviral Treatment Guidelines. Department of Health (South Africa), Johannesburg, South Africa.
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. 1st edn, PLoS Medicine 4, e298.
  • Sepulveda J, Carpenter C, Curran J et al. (2007) PEPFAR Implementation: Progress and Promise. Institute of Medicine of the National Academy of Sciences, The National Academies Press, Washington, D.C..
  • Setel PW, Macfarlane SB, Szreter S et al. (2007) A scandal of invisibility: making everyone count by counting everyone. Lancet 370, 15691577.
  • Statistics South Africa (2005) Mortality and Causes of Death in South Africa, 1997–2003. Findings from Death Notification. Statistics South Africa, Pretoria, South Africa.
  • Timaeus I, Dorrington R, Bradshaw D & Nannan N (2002). Mortality Trends in South Africa 1985–2000. From Apartheid to AIDS. South African Medical Research Council, Cape Town.
  • WHO (2005a) Progress Report on Global Access to Antiretroviral Therapy. An Update on 3 by 5. WHO, Geneva.
  • WHO (2005b) Antiretroviral Therapy Coverage in Low- and Middle-Income Countries, by Region Situation as of June 2005. WHO, Geneva.
  • WHO, UNAIDS, UNICEF (2008) Towards Universal Acess. Scaling up Priority HIV/AIDS Interventions in the Health Sector. Progress Report, April 2008. WHO, Geneva.
  • Yiannoutsos CT, An MW, Frangakis CE et al. (2008) Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE 3, e3843.